APEX1 and lung cancer: As the genomic sequences of RAGE and APE1 genes are highly polymorphic, it is of added interest to identify which genetic defect(s) might have functional potentials to affect the final bioavailability of these two genes, and thus to the pathogenesis of lung cancer.